Literature DB >> 30317231

Uterine Carcinosarcomas - Diagnosis and Management.

Dominik Denschlag, Uwe A Ulrich.   

Abstract

Uterine carcinosarcomas are rare tumors that account for less than 5% of all uterine malignancies. These tumors (previously called malignant mixed Müllerian tumors) are dedifferentiated carcinomas that comprise carcinomatous and sarcomatous elements and arise from a single malignant clone. They are considered a high-risk variant of endometrial adenocarcinoma because carcinosarcomas share more similarities in epidemiology, risk factors, and clinical behavior with endometrial carcinoma than with uterine sarcomas. The clinical features, diagnosis, staging, and treatment of uterine carcinosarcoma will be discussed in this review.
© 2018 S. Karger GmbH, Freiburg.

Entities:  

Keywords:  Chemotherapy; Endometrial cancer; Sarcoma

Mesh:

Year:  2018        PMID: 30317231     DOI: 10.1159/000494335

Source DB:  PubMed          Journal:  Oncol Res Treat        ISSN: 2296-5270            Impact factor:   2.825


  12 in total

1.  A Rare Case of Intracavitary Cardiac Metastasis of Endometrial Carcinosarcoma.

Authors:  Masi Javeed; Raghav Ravuri; Zaydi Javeed; Shawn Taylor; Rami Akel
Journal:  Cureus       Date:  2022-06-01

2.  Educational Case: Metastatic endometrial stromal sarcoma presenting as bone pain: a diagnostic approach to uterine mesenchymal tumors.

Authors:  Terri E Jones; Samer Khader; Mirka W Jones; Sigfred B Lajara
Journal:  Acad Pathol       Date:  2022-05-13

3.  Role of minimally invasive surgery versus open approach in patients with early-stage uterine carcinosarcomas: a retrospective multicentric study.

Authors:  Giacomo Corrado; Francesca Ciccarone; Francesco Cosentino; Francesco Legge; Andrea Rosati; Martina Arcieri; Luigi Carlo Turco; Camilla Certelli; Alex Federico; Enrico Vizza; Francesco Fanfani; Giovanni Scambia; Gabriella Ferrandina
Journal:  J Cancer Res Clin Oncol       Date:  2020-09-03       Impact factor: 4.553

4.  Uterine Carcinosarcoma in a Young Female: Case Report and Literature Review.

Authors:  Noha N Soror; Daniel Woredekal; Lori Hemrock; Gary Gibson; Robert Bennett
Journal:  Cureus       Date:  2021-01-11

5.  Atypical Polypoid Adenomyoma of the Vagina: Follow Up and Subsequent Evolution: A Case Report and Update.

Authors:  Melinda Ildiko Mitranovici; Ioan Emilian Oală; Izabella Petre; Marius Lucian Craina; Silviana Narcisa Floruț; Diana Maria Chiorean; Iuliu Gabriel Cocuz; Sabin Gligore Turdean; Ovidiu Simion Cotoi; Lucian Pușcașiu
Journal:  Diagnostics (Basel)       Date:  2022-02-01

6.  Construction and comprehensive analysis of the competing endogenous RNA network in endometrial adenocarcinoma.

Authors:  Chong Feng; Lei Cui; Zhen Jin; Lei Sun; Xiaoyan Wang; Xinshu Chi; Qian Sun; Siyu Lian
Journal:  BMC Genom Data       Date:  2022-02-06

7.  Immune Cell Infiltration as Signatures for the Diagnosis and Prognosis of Malignant Gynecological Tumors.

Authors:  Qi-Fang Liu; Zi-Yi Feng; Li-Li Jiang; Tong-Tong Xu; Si-Man Li; Kui-Ran Liu
Journal:  Front Cell Dev Biol       Date:  2021-06-17

8.  Carcinosarcomas of the Uterus: Prognostic Factors and Impact of Adjuvant Treatment.

Authors:  Kerri Beckmann; Sudarshan Selva-Nayagam; Ian Olver; Caroline Miller; Elizabeth S Buckley; Kate Powell; Dianne Buranyi-Trevarton; Raghu Gowda; David Roder; Martin K Oehler
Journal:  Cancer Manag Res       Date:  2021-06-10       Impact factor: 3.989

9.  Intradural extramedullary spinal metastases from uterine carcinosarcoma: A case report.

Authors:  Sharath Kumar Anand; Richard Justin Garling; Jessica Johns; Manan Shah; Parthasarathi Chamiraju
Journal:  Surg Neurol Int       Date:  2020-10-21

10.  The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas.

Authors:  Lea A Moukarzel; Lorenzo Ferrando; Arnaud Da Cruz Paula; David N Brown; Felipe C Geyer; Fresia Pareja; Salvatore Piscuoglio; Anastasios D Papanastasiou; Nicola Fusco; Caterina Marchiò; Nadeem R Abu-Rustum; Rajmohan Murali; Edi Brogi; Hannah Y Wen; Larry Norton; Robert A Soslow; Anne Vincent-Salomon; Jorge S Reis-Filho; Britta Weigelt
Journal:  Mol Oncol       Date:  2021-02-19       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.